Jacobs Levy Equity Management, Inc Axcella Health Inc. Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.08 - $5.13 $397,652 - $662,324	-129,108 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $263,963 - $389,854	-58,014 Reduced 31.0%	129,108 $615,000
Q4 2020 Feb 16, 2021	SELL	$4.24 - $5.97 $33,224 - $46,780	-7,836 Reduced 4.02%	187,122 $971,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $5.91 $540,115 - $774,777	131,096 Added 205.28%	194,958 $901,000
Q2 2020 Aug 17, 2020	BUY	$2.94 - $7.7 $187,754 - $491,737	63,862 New	63,862 $353,000
Q1 2020 May 15, 2020	SELL	$2.25 - $5.24 $33,300 - $77,552	-14,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.08 - $5.9 $45,584 - $87,320	14,800 New	14,800 $59,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.